[go: up one dir, main page]

JP2008007411A - Transglutaminase production promoter and epidermal keratinization-normalizing agent - Google Patents

Transglutaminase production promoter and epidermal keratinization-normalizing agent Download PDF

Info

Publication number
JP2008007411A
JP2008007411A JP2006176085A JP2006176085A JP2008007411A JP 2008007411 A JP2008007411 A JP 2008007411A JP 2006176085 A JP2006176085 A JP 2006176085A JP 2006176085 A JP2006176085 A JP 2006176085A JP 2008007411 A JP2008007411 A JP 2008007411A
Authority
JP
Japan
Prior art keywords
transglutaminase
extract
transglutaminase production
skin
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006176085A
Other languages
Japanese (ja)
Inventor
Akinori Kiso
昭典 木曽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruzen Pharmaceutical Co Ltd
Original Assignee
Maruzen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruzen Pharmaceutical Co Ltd filed Critical Maruzen Pharmaceutical Co Ltd
Priority to JP2006176085A priority Critical patent/JP2008007411A/en
Publication of JP2008007411A publication Critical patent/JP2008007411A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a transglutaminase production promoter and an epidermal keratinization-normalizing agent by finding an ingredient having enzyme transglutaminase production promoting action essential for CE (cornified envelope) formation in epidermis from natural products and including the ingredient as an active ingredient. <P>SOLUTION: The present invention utilizes that one or more kinds of extracts of plants selected from Equisetum arvense L., Luffa cylindrica M. Roemen, Citrus aurantium L., Paeonia suffruticosa Andrews, Citrus unshiu Markovich, Hypericum erectum Thunb. or Hypericum perforatum L, Morus bombycis Koidzumi, Curcuma longa L., Melissa officinalis L., Lavandula vera D.C., Ganoderma lucidum(Fr.)Karst. and Rosmarinus officinalis L. have transglutaminase production promoting action and karatinization-normalizing action. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、植物からの抽出物を有効成分とするトランスグルタミナーゼ産生促進剤及び
表皮角化正常化剤に関する。
The present invention relates to a transglutaminase production promoter and an epidermal keratinization normalizing agent comprising an extract from a plant as an active ingredient.

皮膚は、外界からの刺激、例えば、乾燥、紫外線、その他の物理的、化学的刺激を緩和したり、水分等の体内成分の喪失を防御する機能を有している。この重要な機能は、皮膚のバリア機能と呼ばれ、その機能維持に重要な役割を担っているのが角層である。
角層は、表皮角化細胞が終末分化して形成された角質細胞と、細胞間を埋める細胞間脂質から形成される。セラミドを主成分とする細胞間脂質は、ラメラ構造を形成することにより、角層バリア機能を担っている。一方、角質細胞は、ケラチン線維を主成分とし、膜の裏打ち蛋白であるコーニファイドエンベロープ(角質肥厚膜、以下「CE」と略)という疎水的で強靭な細胞膜様構造物に覆われている。CEは、表皮角化細胞の分化に従って細胞内で産生されるインボルクリン、ロリクリンなど複数のCE前駆体蛋白質が、酵素トランスグルタミナーゼにより架橋され不溶化して形成され、このCEが皮膚のバリア機能に密接に関与している。さらに、その一部にはセラミド等が共有結合し、疎水的な構造をとることで細胞間脂質のラメラ構造の土台を供給し、角層バリア機能及び皮膚の水分保持機能の基礎が形成される。
The skin has a function of mitigating external stimuli such as dryness, ultraviolet rays, and other physical and chemical stimuli, and protecting the loss of body components such as moisture. This important function is called a skin barrier function, and the stratum corneum plays an important role in maintaining the function.
The stratum corneum is formed from keratinocytes formed by terminal differentiation of epidermal keratinocytes and intercellular lipids that fill the space between the cells. Intercellular lipids mainly composed of ceramide have a stratum corneum barrier function by forming a lamellar structure. On the other hand, keratinocytes are mainly composed of keratin fibers and covered with a hydrophobic and strong cell membrane-like structure called a cornified envelope (keratin thickened membrane, hereinafter abbreviated as “CE”) which is a membrane lining protein. CE is formed by cross-linking and insolubilizing a plurality of CE precursor proteins such as involucrin and loricrin produced in the cells according to the differentiation of epidermal keratinocytes, and this CE is closely related to the barrier function of the skin. Is involved. Furthermore, ceramide and the like are covalently bonded to some of them, and the base of the lamellar structure of the intercellular lipid is supplied by taking a hydrophobic structure, and the basis of the stratum corneum barrier function and the moisture retention function of the skin is formed. .

角質細胞は、表皮角化細胞の分化(角化)によって次々と新しく作られ、古くなった角質細胞は垢として角層から脱落していく。これが、皮膚のターンオーバーと言われる現象である。ターンオーバーのサイクルは、正常な皮膚では約4週間と言われているが、加齢、乾燥、紫外線などの影響によりターンオーバー速度に異常が生じると、ラメラ構造の乱れやCEが不完全な状態で形成された、いわゆる不全角化が誘発され、角質細胞や細胞間脂質の構造に異常が生じ角層の水分保持機能およびバリア機能は低下する。このことが肌荒れ、乾燥肌等の皮膚の老化症状につながると考えられる。また、乾癬やアトピー性皮膚炎の患者では、バリア機能が低下した皮疹部で未熟なCEが高頻度に観察され、CEが正しく形成されることが皮膚のバリア機能に非常に重要であると考えられている(非特許文献1)。   The keratinocytes are newly created one after another by the differentiation (keratinization) of the epidermal keratinocytes, and the old keratinocytes fall off from the stratum corneum as plaque. This is a phenomenon called skin turnover. It is said that the turnover cycle is about 4 weeks for normal skin, but if the turnover speed becomes abnormal due to the effects of aging, drying, ultraviolet rays, etc., the lamella structure is disturbed and CE is incomplete. In other words, the so-called aberrant keratinization is induced, the structure of corneocytes and intercellular lipids is abnormal, and the water retention function and barrier function of the stratum corneum are reduced. This is thought to lead to skin aging symptoms such as rough skin and dry skin. In patients with psoriasis and atopic dermatitis, immature CE is frequently observed in the skin area where the barrier function is reduced, and the correct formation of CE is very important for the barrier function of the skin. (Non-Patent Document 1).

即ち、表皮においてトランスグルタミナーゼやインボルクリンの産生を促進することにより角質細胞の角化を促進し、健全な角層の形成を促すことによって、皮膚のバリア機能および水分保持機能を高め、乾燥肌、荒れ肌、アトピー性皮膚炎、乾癬などの皮膚症状を予防又は改善することができると考えられる。このような考えに基づき、トランスグルタミナーゼ産生促進作用を有するものとして、湖南甜茶抽出物とその酸加水分解物(特許文献1)、フロリジン及びフロレチン(特許文献2)、ビタミンD及びその関連化合物(特許文献3)、マツヨイグサ属植物の抽出物(特許文献4)等が知られている。
特願2005−292445号公報 特願2005−300388号公報 特開2004−115451号公報 特開2004−91376号公報 Experimental Dermatology 12:591−601(2003)
That is, by promoting the production of transglutaminase and involucrin in the epidermis, keratinization of keratinocytes is promoted, and the formation of a healthy stratum corneum is promoted, so that the skin barrier function and water retention function are enhanced, dry skin, rough skin It is considered that skin symptoms such as atopic dermatitis and psoriasis can be prevented or ameliorated. Based on this idea, as one having a transglutaminase production-promoting action, Hunan cocoon tea extract and its acid hydrolyzate (patent document 1), phlorizin and phloretin (patent document 2), vitamin D and related compounds (patent) Document 3), extracts of genus Oenothera (Patent Document 4) and the like are known.
Japanese Patent Application No. 2005-292445 Japanese Patent Application No. 2005-300388 JP 2004-115451 A JP 2004-91376 A Experimental Dermatology 12: 591-601 (2003)

しかしながら、これまで角層バリア機能の低下に用いられていた成分は、細胞間脂質の成分を補うことや、皮膚に被膜を形成させることにより皮膚バリア機能の改善効果を発揮していたが、角質細胞のCEの構造については改善効果が十分でない場合もあり、健全なCEの形成に働きかける成分の開発が望まれていた。   However, the components that have been used to lower the stratum corneum barrier function so far have been effective in improving the skin barrier function by supplementing the components of intercellular lipids and forming a film on the skin. The improvement of the CE structure of the cells may not be sufficient, and it has been desired to develop a component that works to form a healthy CE.

そこで本発明においては、天然物の中から、表皮においてCE形成に不可欠な酵素トランスグルタミナーゼの産生促進作用を有する成分を見出し、これを有効成分として含有するトランスグルタミナーゼ産生促進剤並びに表皮角化正常化剤を提供することを目的とした。   Therefore, in the present invention, a component having an action of promoting the production of enzyme transglutaminase essential for CE formation in the epidermis is found from natural products, and a transglutaminase production promoter containing this as an active ingredient and normalization of epidermal keratinization The purpose was to provide an agent.

前記課題を解決するために、種々検討を行ったところ、スギナ、ヘチマ、ダイダイ、ボタン、ウンシュウミカン、オトギリソウ、クワ、ウコン、メリッサ、ラベンダー、レイシ及びローズマリーから選ばれる1種又は2種以上の植物抽出物にトランスグルタミナーゼ産生促進作用を見出し、本発明を完成するに至った。   In order to solve the above-mentioned problems, various studies have been conducted. As a result, one or more kinds selected from Sugina, Loofah, Daidai, Button, Satsumikan, Hypericum, Mulberry, Turmeric, Melissa, Lavender, Reishi and Rosemary are selected. A plant extract was found to promote transglutaminase production, and the present invention was completed.

本発明によると、スギナ、ヘチマ、ダイダイ、ボタン、ウンシュウミカン、オトギリソウ、クワ、ウコン、メリッサ、ラベンダー、レイシ及びローズマリーから選ばれる1種又は2種以上の植物抽出物を含有してなるトランスグルタミナーゼ産生促進剤が、優れた表皮トランスグルタミナーゼ産生促進作用を有し、表皮角質細胞の正常化による乾燥肌、荒れ肌、アトピー性皮膚炎、乾癬などの皮膚症状の予防・改善を効果的に行うことができる。   According to the present invention, transglutaminase containing one or more plant extracts selected from cedar, loofah, daidai, button, shrimp, hypericum, mulberry, turmeric, melissa, lavender, litchi and rosemary. The production promoter has an excellent epidermal transglutaminase production promoting effect, and can effectively prevent and improve skin symptoms such as dry skin, rough skin, atopic dermatitis, psoriasis due to normalization of epidermal keratinocytes it can.

本発明のトランスグルタミナーゼ産生促進剤は、スギナ、ヘチマ、ダイダイ、ボタン、ウンシュウミカン、オトギリソウ、クワ、ウコン、メリッサ、ラベンダー、レイシ及びローズマリーから選ばれる1種又は2種以上の植物抽出物を含有してなり、さらに必要に応じてその他の成分を含有してなる。   The transglutaminase production promoter of the present invention contains one or more plant extracts selected from cedar, loofah, daidai, button, mandarin orange, hypericum, mulberry, turmeric, melissa, lavender, litchi and rosemary. In addition, it contains other components as required.

前記スギナは、トクサ科(Equisetaceae)の植物であり、学名はEquisetum arvense L.である。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、特に全草が好ましい。   The horsetail is a plant belonging to the family Equisetaceae, and its scientific name is Equisetum arvense L. et al. It is. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, Especially the whole plant is preferable.

前記ヘチマは、ウリ科(Cucurbitaceae)の植物であり、学名はLuffa cylindrica M.Roemenである。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、花、蕾、果実、果皮、果核、地上部またはこれらの混合物が挙げられる。これらの中でも特に地上部を用いることが好ましい。   The loofah is a plant of the Cucurbitaceae family, and its scientific name is Luffa cylindrica M. et al. Roemen. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, For example, a leaf, a stem, a flower, a bud, a fruit, a fruit skin, a fruit core, an above-ground part, or these mixtures are mentioned. Among these, it is particularly preferable to use the above-ground part.

前記ダイダイは、ミカン科(Rutaceae)の植物であり、学名はCitrus aurantium L.である。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、花、蕾、果実、果皮、果核、地上部、全草またはこれらの混合物が挙げられる。これらの中でも特に果皮が好ましい。   The Daidai is a plant of the Rutaceae family, and its scientific name is Citrus aurantium L. It is. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, For example, a leaf, a stem, a flower, a bud, a fruit, a fruit skin, a fruit core, an above-ground part, whole grass, or these mixtures are mentioned. Of these, the peel is particularly preferred.

前記ボタンは、ボタン科(Paeoniaceae)の植物であり、学名はPaeonia suffruticosa Andrewsである。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、花、根、根皮、地上部またはこれらの混合物が挙げられる。これらの中でも特に根皮を用いることが好ましい。   The button is a plant of the Paeoniaceae family and the scientific name is Paeonia suffrificosa Andrews. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, For example, a leaf, a stem, a flower, a root, a root bark, an above-ground part, or these mixtures are mentioned. Of these, root bark is particularly preferred.

前記ウンシュウミカンは、ミカン科(Rutaceae)の植物であり、学名はCitrus unshiu Markovichである。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、枝、花、蕾、果実、果皮、果核、地上部、全草またはこれらの混合物が挙げられる。これらの中でも特に果皮を用いることが好ましい。   The Citrus unshiu is a plant belonging to the family Rutaceae, and its scientific name is Citrus unshiu Markovich. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, For example, a leaf, a stem, a branch, a flower, a cocoon, a fruit, a fruit skin, a fruit core, an above-ground part, whole grass, or a mixture thereof is mentioned. Among these, it is particularly preferable to use a peel.

前記オトギリソウは、オトギリソウ科(Guttiferae)の植物であり、学名はHypericum erectum Thunb.またはHypericum perforatum L.である。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、根、花、地上部、全草またはこれらの混合物が挙げられる。これらの中でも地上部又は全草を用いることが好ましい。   The hypericum is a plant of the family Glutiferae, and its scientific name is Hypericum electum Thumb. Or Hypericum performancea L. It is. There is no restriction | limiting in particular in a structural part, According to the objective, it can select suitably, For example, a leaf, a stem, a root, a flower, an above-ground part, whole grass, or a mixture thereof is mentioned. Among these, it is preferable to use the above-ground part or whole grass.

前記クワは、クワ科(Moraceae)の植物であり、学名はMorus bombycis Koidzumiである。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、花、根、根皮、地上部またはこれらの混合物が挙げられる。これらの中でも特に根皮を用いることが好ましい。   The mulberry is a plant belonging to the family Moraceae, and its scientific name is Morus bombycis Koidzumi. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, For example, a leaf, a stem, a flower, a root, a root bark, an above-ground part, or these mixtures are mentioned. Of these, root bark is particularly preferred.

前記ウコンは、ショウガ科(Zingiberaceae)の植物であり、学名はCurcuma longa L.である。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、花、蕾、根茎、地上部またはこれらの混合物が挙げられる。これらの中でも特に根茎を用いることが好ましい。   The turmeric is a plant belonging to the family Zingiberaceae and has a scientific name of Curcuma longa L. It is. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, For example, a leaf, a stem, a flower, a bud, a rhizome, an above-ground part, or these mixtures are mentioned. Among these, it is particularly preferable to use a rhizome.

前記メリッサは、シソ科(Labiatae)の植物であり、学名はMelissa officinalis L.である。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、根、花、果実、果皮、果核、全草またはこれらの混合物が挙げられる。これらの中でも特に葉を用いることが好ましい。   The Melissa is a plant of the Labiatae family and has a scientific name of Melissa officinalis L. It is. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, For example, a leaf, a stem, a root, a flower, a fruit, a fruit peel, a fruit nucleus, whole grass, or a mixture thereof is mentioned. Among these, it is particularly preferable to use leaves.

前記ラベンダーは、シソ科(Labiatae)の植物であり、学名はLavandula vera D.C.である。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、花、根、果実、果皮、果核またはこれらの混合物が挙げられる。これらの中でも特に花を用いることが好ましい。   The lavender is a plant belonging to the family Labiatae, and the scientific name is Lavandula vera D. et al. C. It is. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, For example, a leaf, a stem, a flower, a root, a fruit, a fruit skin, a fruit nucleus, or a mixture thereof is mentioned. Among these, it is particularly preferable to use flowers.

前記レイシは、サルノコシカケ科(Polyporaceae)の植物であり、学名はGanoderma lucidum(Fr.)Karst.である。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、特に子実体を用いることが好ましい。   The litchi is a plant of the Polypoaceae family, and has a scientific name of Ganoderma lucidum (Fr.) Karst. It is. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, It is preferable to use a fruit body especially.

前記ローズマリーは、シソ科(Labiatae)の植物であり、学名はRosmarinus officinalis L.である。 構成部位は特に制限はなく、目的に応じて適宜選定することができ、例えば葉、茎、花、蕾、果実、果皮、果核、地上部、全草またはこれらの混合物が挙げられる。これらの中でも特に葉を用いることが好ましい。   The rosemary is a plant of the Labiatae family and has a scientific name of Rosmarinus officinalis L. It is. There is no restriction | limiting in particular in a structure part, According to the objective, it can select suitably, For example, a leaf, a stem, a flower, a bud, a fruit, a fruit skin, a fruit core, an above-ground part, whole grass, or these mixtures are mentioned. Among these, it is particularly preferable to use leaves.

なお、前記スギナ、ヘチマ、ダイダイ、ボタン、ウンシュウミカン、オトギリソウ、クワ、ウコン、メリッサ、ラベンダー、レイシ及びローズマリーから選ばれる1種又は2種以上の植物抽出物が含有する有効成分であるトランスグルタミナーゼ産生促進作用物質の詳細については不明であるが、これらの有効成分は植物の抽出に一般に用いられている方法により抽出したものを使用してもよいし、市販品を使用してもよい。前記抽出物には、抽出処理によって抽出原料から得られる抽出液、該抽出液の希釈液もしくは濃縮液、該抽出液を乾燥して得られる乾燥物、又はこれらの粗精製物もしくは精製物のいずれもが含まれる。   In addition, transglutaminase which is an active ingredient contained in one or more plant extracts selected from the above cedar, loofah, daidai, button, unshimikan, hypericum, mulberry, turmeric, melissa, lavender, litchi and rosemary Although details of the production promoting substance are unknown, those active ingredients may be extracted by a method generally used for plant extraction, or commercially available products may be used. The extract includes any one of an extract obtained from an extraction raw material by an extraction process, a diluted or concentrated solution of the extract, a dried product obtained by drying the extract, or a roughly purified product or a purified product thereof. Is also included.

前記抽出原料は、採取後ただちに乾燥し粉砕したものが適当である。乾燥は天日で行ってもよいし、通常使用される乾燥機を用いて行ってもよい。また、ヘキサン、ベンゼン等の非極性溶媒によって脱脂等の前処理を施してから抽出原料として使用してもよい。   The extraction raw material is suitably dried and pulverized immediately after collection. Drying may be performed in the sun or using a commonly used dryer. Moreover, after performing pre-processing, such as degreasing, with nonpolar solvents, such as hexane and benzene, you may use as an extraction raw material.

前記抽出に用いる溶媒としては、水若しくは親水性有機溶媒又はこれらの混合液を室温又は溶媒の沸点以下の温度で用いることが好ましい。各植物に含まれるトランスグルタミナーゼ産生促進作用を示す成分は、極性溶媒を抽出溶媒とする抽出処理によって容易に抽出することができる。   As the solvent used for the extraction, it is preferable to use water, a hydrophilic organic solvent, or a mixture thereof at room temperature or a temperature not higher than the boiling point of the solvent. A component showing the transglutaminase production promoting action contained in each plant can be easily extracted by an extraction treatment using a polar solvent as an extraction solvent.

前記抽出溶媒として使用し得る水としては、例えば、純水、水道水、井戸水、鉱泉水、鉱水、温泉水、湧水、淡水等の他、これらに各種処理を施したものが含まれる。水に施す処理としては、例えば、精製、加熱、殺菌、ろ過、イオン交換、浸透圧の調整、緩衝化等が含まれる。従って、本発明において抽出溶媒として使用し得る水には、精製水、熱水、イオン交換水、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等も含まれる。   Examples of water that can be used as the extraction solvent include pure water, tap water, well water, mineral spring water, mineral water, hot spring water, spring water, fresh water, and the like, as well as water that has been subjected to various treatments. Examples of the treatment applied to water include purification, heating, sterilization, filtration, ion exchange, adjustment of osmotic pressure, buffering, and the like. Therefore, the water that can be used as the extraction solvent in the present invention includes purified water, hot water, ion-exchanged water, physiological saline, phosphate buffer, phosphate buffered saline, and the like.

前記親水性有機溶媒としては、例えば、メタノール、エタノール、プロピルアルコール、イソプロピルアルコール等の炭素数1〜5の低級アルコール;アセトン、メチルエチルケトン等の低級脂肪族ケトン;1,3−ブチレングリコール、プロピレングリコール、グリセリン等の炭素数2〜5の多価アルコールなどが挙げられ、該親水性有機溶媒と水との混合溶媒などを用いることができる。   Examples of the hydrophilic organic solvent include lower alcohols having 1 to 5 carbon atoms such as methanol, ethanol, propyl alcohol, and isopropyl alcohol; lower aliphatic ketones such as acetone and methyl ethyl ketone; 1,3-butylene glycol, propylene glycol, Examples thereof include polyhydric alcohols having 2 to 5 carbon atoms such as glycerin, and a mixed solvent of the hydrophilic organic solvent and water can be used.

なお、前記水と親水性有機溶媒との抽出溶媒を使用する場合には、低級アルコールの場合は水10質量部に対して1〜90質量部、低級脂肪族ケトンの場合は水10質量部に対して1〜40質量部添加することが好ましい。多価アルコールの場合は水10質量部に対して1〜90質量部添加することが好ましい。   In addition, when using the extraction solvent of the said water and a hydrophilic organic solvent, in the case of a lower alcohol, it is 1-90 mass parts with respect to 10 mass parts of water, and in the case of a lower aliphatic ketone, it is 10 mass parts of water. It is preferable to add 1-40 mass parts with respect to it. In the case of a polyhydric alcohol, it is preferable to add 1 to 90 parts by mass with respect to 10 parts by mass of water.

本発明において、前記各抽出原料からトランスグルタミナーゼ産生促進物質を抽出するにあたって特殊な抽出方法を採用する必要はなく、室温又は還流加熱下で、任意の装置を用いて抽出することができる。   In the present invention, it is not necessary to employ a special extraction method for extracting the transglutaminase production promoting substance from each extraction raw material, and the extraction can be performed using an arbitrary apparatus at room temperature or under reflux heating.

具体的には、抽出溶媒を満たした処理槽に各抽出原料を投入し、更に必要に応じて時々攪拌しながら、30分〜4時間静置して可溶性成分を溶出した後、ろ過して固形物を除去し、得られた抽出液から抽出溶媒を留去し、乾燥することにより抽出物が得られる。抽出溶媒量は通常、抽出原料の5〜15倍量(質量比)である。抽出条件は、抽出溶媒として水を用いた場合には、通常50〜95℃で1〜4時間程度である。また、抽出溶媒として水とエタノールとの混合溶媒を用いた場合には、通常40〜80℃で30分〜4時間程度である。なお、溶媒で抽出することにより得られる抽出液は、抽出溶媒が安全性の高いものであればそのまま配合して本発明のトランスグルタミナーゼ産生促進剤及び/又は表皮角化正常化剤の有効成分として使用することができるが、濃縮液又はその乾燥物としたものの方が利用しやすい。   Specifically, each extraction raw material is put into a treatment tank filled with an extraction solvent, and further, while stirring occasionally as necessary, the mixture is allowed to stand for 30 minutes to 4 hours to elute soluble components, and then filtered and solidified. An extract is obtained by removing a thing, distilling an extraction solvent off from the obtained extract, and drying. The amount of the extraction solvent is usually 5 to 15 times (mass ratio) of the extraction raw material. The extraction condition is usually about 1 to 4 hours at 50 to 95 ° C. when water is used as the extraction solvent. Moreover, when using the mixed solvent of water and ethanol as an extraction solvent, it is about 30 minutes-4 hours at 40-80 degreeC normally. In addition, the extract obtained by extracting with a solvent, if the extraction solvent is highly safe, is blended as it is as an active ingredient of the transglutaminase production promoter and / or epidermal keratinization normalizing agent of the present invention. Although it can be used, it is easier to use a concentrated solution or a dried product thereof.

得られた抽出液は、該抽出液の希釈液若しくは濃縮液、該抽出液の乾燥物、又はこれらの粗精製物若しくは精製物を得るために、常法に従って希釈、濃縮、乾燥、精製等の処理を施してもよい。   The obtained extract is diluted, concentrated, dried, purified, etc. according to a conventional method in order to obtain a diluted or concentrated solution of the extract, a dried product of the extract, or a crude purified product or a purified product thereof. Processing may be performed.

なお、得られた抽出液はそのままでもトランスグルタミナーゼ産生促進剤及び/又は表皮角化正常化剤として使用することができるが、濃縮液又はその乾燥物としたものの方が利用しやすい。乾燥物を得るにあたっては、吸湿性を改善するためにデキストリン、シクロデキストリン等のキャリアーを添加してもよい。   In addition, although the obtained extract can be used as it is as a transglutaminase production promoter and / or a skin keratinization normalizing agent, a concentrated solution or a dried product thereof is easier to use. In obtaining a dried product, a carrier such as dextrin or cyclodextrin may be added to improve hygroscopicity.

また、各抽出原料は特有の匂いと味を有しているため、その生理活性の低下を招かない範囲で脱色、脱臭等を目的とする精製を行うことも可能であるが、化粧料に添加する場合には大量に使用するものではないから、未精製のままでも実用上支障はない。精製は、具体的には活性炭処理、吸着樹脂処理、イオン交換樹脂処理等によって行うことができる。   In addition, since each extraction raw material has a unique odor and taste, it is possible to carry out purification for the purpose of decolorization, deodorization, etc. within a range that does not cause a decrease in its physiological activity, but it is added to cosmetics. In this case, since it is not used in large quantities, there is no practical problem even if it is not purified. Specifically, purification can be performed by activated carbon treatment, adsorption resin treatment, ion exchange resin treatment, or the like.

本発明のトランスグルタミナーゼ産生促進剤及び/又は表皮角化正常化剤は、製剤化により粉末状、顆粒状、錠剤状等、任意の剤形とすることができる。   The transglutaminase production promoter and / or epidermal keratinization normalizing agent of the present invention can be made into any dosage form such as powder, granule, tablet, etc. by formulation.

以下、本発明の実施例を説明するが、本発明は、これらの実施例に何ら限定されるものではない。なお、本実施例で使用する、前記スギナ抽出液、ヘチマ抽出液−JC、トウヒ抽出液、ボタンピ抽出液、チンピ抽出液、オトギリソウ抽出液−J、ソウハクヒ抽出液、ウコン抽出液−J、メリッサ抽出液−J、ラベンダー抽出液、レイシ抽出液及びローズマリー抽出液(全て丸善製薬社製)の各凍結乾燥品を試料として用いた。   Examples of the present invention will be described below, but the present invention is not limited to these examples. In addition, the said horsetail extract, loofah extract-JC, spruce extract, button pi extract, chimpi extract, hypericum extract-J, Soraku extract, turmeric extract-J, Melissa extract used in this Example Each lyophilized product of liquid-J, lavender extract, litchi extract and rosemary extract (all manufactured by Maruzen Pharmaceutical Co., Ltd.) was used as a sample.

[試験例1]トランスグルタミナーゼ産生促進作用試験
上記の各抽出物について、下記の方法によりトランスグルタミナーゼ産生促進作用の試験をした。
[Test Example 1] Transglutaminase production promoting action test
Each of the above extracts was tested for the effect of promoting transglutaminase production by the following method.

正常ヒト皮膚表皮角化細胞(NHEK)を80cmのフラスコで正常ヒト表皮角化細胞培地(KGM)にて37℃、5%CO下で培養し、トリプシン処理により細胞を回収した。回収した細胞を1.0×10個/mLの細胞密度となるようにKGMで希釈した後、96ウェルプレートに1ウェルあたり100μLずつ播種し、5%CO下、37℃で2日間培養した。 Normal human skin epidermal keratinocytes (NHEK) were cultured in normal human epidermal keratinocyte medium (KGM) at 37 ° C. and 5% CO 2 in an 80 cm 2 flask, and the cells were collected by trypsin treatment. The collected cells are diluted with KGM to a cell density of 1.0 × 10 5 cells / mL, then seeded at 100 μL per well in a 96-well plate, and cultured at 37 ° C. under 5% CO 2 for 2 days. did.

培養終了後、KGMで溶解した試料溶液を各ウェルに100μLずつ添加し、37℃、5%CO下で24時間培養した。培養終了後、 培地を抜き、細胞をプレートに固定させ細胞表面に発現したトランスグルタミナーゼの量をモノクローナル抗ヒトトランスグルタミナーゼ-1抗体を用いたELISA法により測定した。得られた測定結果から、下記式によりトランスグルタミナーゼ産生促進率(%)を算出した。
トランスグルタミナーゼ産生促進率(%)=A / B × 100
式中、Aは「試料添加時の波長405nmにおける吸光度」を表し、Bは「試料無添加時の波長405nmにおける吸光度」を表す。
After completion of the culture, 100 μL of a sample solution dissolved in KGM was added to each well and cultured at 37 ° C. under 5% CO 2 for 24 hours. After completion of the culture, the medium was removed, the cells were fixed on a plate, and the amount of transglutaminase expressed on the cell surface was measured by ELISA using a monoclonal anti-human transglutaminase-1 antibody. From the obtained measurement results, the transglutaminase production promotion rate (%) was calculated by the following formula.
Transglutaminase production promotion rate (%) = A / B × 100
In the formula, A represents “absorbance at a wavelength of 405 nm when a sample is added”, and B represents “absorbance at a wavelength of 405 nm when no sample is added”.

上記試験の結果を表1〜12に示す。なお、上記計算式において、試料無添加のトランスグルタミナーゼ産生促進率は100%となる。   The result of the said test is shown to Tables 1-12. In the above calculation formula, the rate of acceleration of transglutaminase production without addition of the sample is 100%.

[表1]
スギナの全草抽出物の添加濃度 トランスグルタミナーゼ産生促進率
100.0μ g/mL 106.1%
25.0μ g/mL 114.1%
[Table 1]
Transglutaminase production promotion rate of added concentration of Japanese horsetail extracts
100.0 μg / mL 106.1%
25.0 μg / mL 114.1%

[表2]
ヘチマの地上部抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 104.8%
12.5μ g/mL 109.3%
[Table 2]
Transglutaminase production promotion rate of added concentration of aboveground extract of loofah
50.0 μg / mL 104.8%
12.5 μg / mL 109.3%

[表3]
ダイダイの果皮抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 114.8%
12.5μ g/mL 114.3%
[Table 3]
Daigluta pericarp extract concentration concentration transglutaminase production promotion rate
50.0 μg / mL 114.8%
12.5 μg / mL 114.3%

[表4]
ボタンの根皮抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 101.9%
12.5μ g/mL 117.0%
[Table 4]
Button root bark extract addition concentration transglutaminase production promotion rate
50.0 μg / mL 101.9%
12.5 μg / mL 117.0%

[表5]
ウンシュウミカンの果皮抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 116.8%
12.5μ g/mL 104.6%
[Table 5]
Transglutaminase production promotion rate of added concentration of Citrus unshiu peel extract
50.0 μg / mL 116.8%
12.5 μg / mL 104.6%

[表6]
オトギリソウの全草抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 112.4%
12.5μ g/mL 110.7%
[Table 6]
Transglutaminase production promotion rate of added concentration of hypericum whole grass extract
50.0 μg / mL 112.4%
12.5 μg / mL 110.7%

[表7]
クワの根皮抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 107.1%
12.5μ g/mL 107.4%
[Table 7]
Mulberry root bark extract added concentration transglutaminase production promotion rate
50.0 μg / mL 107.1%
12.5 μg / mL 107.4%

[表8]
ウコンの根茎抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 109.6%
12.5μ g/mL 118.9%
[Table 8]
Accelerated rate of transglutaminase production in turmeric rhizome extract
50.0 μg / mL 109.6%
12.5 μg / mL 118.9%

[表9]
メリッサの葉抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 104.0%
12.5μ g/mL 112.2%
[Table 9]
Melissa leaf extract added concentration transglutaminase production promotion rate
50.0 μg / mL 104.0%
12.5 μg / mL 112.2%

[表10]
ラベンダーの花抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 113.3%
12.5μ g/mL 107.2%
[Table 10]
Lavender flower extract added concentration transglutaminase production promotion rate
50.0 μg / mL 113.3%
12.5 μg / mL 107.2%

[表11]
レイシの子実体抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 112.2%
12.5μ g/mL 110.6%
[Table 11]
Transglutaminase production promotion rate of litchi fruiting body extract
50.0 μg / mL 112.2%
12.5 μg / mL 110.6%

[表12]
ローズマリーの葉抽出物の添加濃度 トランスグルタミナーゼ産生促進率
50.0μ g/mL 105.2%
12.5μ g/mL 114.8%
[Table 12]
Increased transglutaminase production rate of rosemary leaf extract
50.0 μg / mL 105.2%
12.5 μg / mL 114.8%

表1〜12に示すように、スギナ、ヘチマ、ダイダイ、ボタン、ウンシュウミカン、オトギリソウ、クワ、ウコン、メリッサ、ラベンダー、レイシ及びローズマリーから選ばれる1種又は2種以上の植物抽出物は、いずれも高いトランスグルタミナーゼ産生促進率を示した。この結果から、これらの抽出物は、優れたトランスグルタミナーゼ産生促進作用を有することが確認された。   As shown in Tables 1 to 12, one or two or more plant extracts selected from horsetail, loofah, daidai, button, mandarin orange, hypericum, mulberry, turmeric, melissa, lavender, lychee and rosemary, Also showed a high transglutaminase production promotion rate. From these results, it was confirmed that these extracts have an excellent transglutaminase production promoting action.

本発明のトランスグルタミナーゼ産生促進剤及び表皮角化正常化剤は、表皮におけるトランスグルタミナーゼの産生促進作用によって表皮角質細胞を正常化させることにより、乾燥肌、荒れ肌、アトピー性皮膚炎、乾癬などの皮膚症状の予防・改善に大きく貢献できる。   The transglutaminase production promoter and epidermal keratinization normalizing agent of the present invention normalizes epidermal keratinocytes by transglutaminase production promoting action in the epidermis, thereby causing skin such as dry skin, rough skin, atopic dermatitis, psoriasis, etc. Can greatly contribute to the prevention and improvement of symptoms.

Claims (2)

スギナ、ヘチマ、ダイダイ、ボタン、ウンシュウミカン、オトギリソウ、クワ、ウコン、メリッサ、ラベンダー、レイシ及びローズマリーから選ばれる1種又は2種以上の植物抽出物を有効成分として含有することを特徴とするトランスグルタミナーゼ産生促進剤。 Trans, comprising as an active ingredient one or more plant extracts selected from Sugina, Loofah, Daidai, Button, Satsuma mandarin, Hypericum, Mulberry, Turmeric, Melissa, Lavender, Ganoderma and Rosemary Glutaminase production promoter. 請求項1記載の植物抽出物を有効成分として含有することを特徴とする表皮角化正常化剤。 A skin keratinizing normalizing agent comprising the plant extract according to claim 1 as an active ingredient.
JP2006176085A 2006-06-27 2006-06-27 Transglutaminase production promoter and epidermal keratinization-normalizing agent Pending JP2008007411A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006176085A JP2008007411A (en) 2006-06-27 2006-06-27 Transglutaminase production promoter and epidermal keratinization-normalizing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006176085A JP2008007411A (en) 2006-06-27 2006-06-27 Transglutaminase production promoter and epidermal keratinization-normalizing agent

Publications (1)

Publication Number Publication Date
JP2008007411A true JP2008007411A (en) 2008-01-17

Family

ID=39065933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006176085A Pending JP2008007411A (en) 2006-06-27 2006-06-27 Transglutaminase production promoter and epidermal keratinization-normalizing agent

Country Status (1)

Country Link
JP (1) JP2008007411A (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009242310A (en) * 2008-03-31 2009-10-22 Kose Corp Involucrin production promoter, transglutaminase-1 production promoter, e-cadherin production promoter and skin care preparation for external use for making skin pore inconspicuous
JP2010105925A (en) * 2008-10-28 2010-05-13 Juntendo Skin keratinization-promoting agent
JP2011088845A (en) * 2009-10-21 2011-05-06 Kao Corp Involucrin expression inhibitor
JP2011088854A (en) * 2009-10-22 2011-05-06 Kao Corp Involucrin expression inhibitor
JP2012171949A (en) * 2011-02-24 2012-09-10 Nagase & Co Ltd Expression enhancer of melatonin receptor and method for producing the same
CN102716393A (en) * 2012-06-13 2012-10-10 陈和平 Externally applied traditional Chinese medicine for treating dermatomycosis and bromhidrosis and preparation method of traditional Chinese medicine
US20140010901A1 (en) * 2011-03-15 2014-01-09 Shiseido Company, Ltd. Bleomycin hydrolase production promotor
JP2014091729A (en) * 2012-11-06 2014-05-19 Fancl Corp Mif secretion inhibitor
JP2014091727A (en) * 2012-11-06 2014-05-19 Fancl Corp Mif secretion inhibitor
KR20170025361A (en) * 2015-08-28 2017-03-08 주식회사 엘지생활건강 Composition for improving skin
JP2017066106A (en) * 2015-09-30 2017-04-06 小林製薬株式会社 Sebum secretion promoter and use thereof
JP2017075117A (en) * 2015-10-14 2017-04-20 丸善製薬株式会社 Barrier function improver
KR20180041107A (en) * 2018-04-16 2018-04-23 주식회사 엘지생활건강 Composition for improving skin
CN107982101A (en) * 2017-11-09 2018-05-04 恩馨(北京)生物科技有限公司 A kind of natural reparative factor, the preparation method and use of effectively reparative regeneration
JP2018127407A (en) * 2017-02-07 2018-08-16 日華化学株式会社 Epidermis normalizing agent and external preparation and cosmetic containing the same
US10071042B2 (en) 2014-04-14 2018-09-11 Hayashibara Co., Ltd. External dermatological agent for anti-ageing
JP2019081712A (en) * 2017-10-27 2019-05-30 丸善製薬株式会社 Nerve growth factor expression inhibitor and semaphorin 3A expression promoter
JP2022161273A (en) * 2021-04-08 2022-10-21 丸善製薬株式会社 Epidermal keratinocyte growth stimulator and transglutaminase-1 mrna expression promoter
JP2023075558A (en) * 2021-11-19 2023-05-31 日本メナード化粧品株式会社 Transglutaminase I production promoter and involucrin production promoter

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58113118A (en) * 1981-12-26 1983-07-05 Nonogawa Shoji:Kk Cosmetic
JPS6253911A (en) * 1985-09-02 1987-03-09 Shiseido Co Ltd Cosmetic
JPS6483013A (en) * 1987-09-24 1989-03-28 Narisu Cosmetic Co Ltd Dermal drug for external use
JPH02184613A (en) * 1989-01-09 1990-07-19 Nonogawa Shoji:Kk Skin cosmetic
JPH04305512A (en) * 1991-03-29 1992-10-28 Shiseido Co Ltd External preparation for skin
JPH0820522A (en) * 1994-07-07 1996-01-23 Pola Chem Ind Inc Keratinizing anzyme activity promoter and cosmetic containing the same
JPH1129460A (en) * 1997-07-04 1999-02-02 Pola Chem Ind Inc Cosmetic for sensitive skin
JPH1160496A (en) * 1997-08-13 1999-03-02 Advanced Sukin Res Kenkyusho:Kk Hyaluronic acid production enhancer
JP2000169383A (en) * 1998-12-07 2000-06-20 Ichimaru Pharcos Co Ltd Antiallergic agent
JP2003171310A (en) * 2002-05-02 2003-06-20 Noevir Co Ltd Skin barrier function-reinforcing agent
JP2003292432A (en) * 2002-04-04 2003-10-15 Noevir Co Ltd Skin care preparation
JP2004091376A (en) * 2002-08-30 2004-03-25 Naris Cosmetics Co Ltd Epidermis keratinization normalizing agent and skin care preparation for external use for skin containing the same
JP2005213178A (en) * 2004-01-29 2005-08-11 Maruzen Pharmaceut Co Ltd TNF-alpha PRODUCTION INHIBITOR, ESTROGENIC AGENT AND EXTERNAL PREPARATION FOR SKIN
JP2006056902A (en) * 2005-10-24 2006-03-02 Shiseido Co Ltd Medicament for pruritus, chapped skin, sensitive skin and whitening by suppressing production/release of stem cell factor
JP2007174931A (en) * 2005-12-27 2007-07-12 Pola Chem Ind Inc Epidermal keratinocyte layer membrane and utilization of the epidermal keratinocyte layer membrane
JP2007176835A (en) * 2005-12-27 2007-07-12 Pola Chem Ind Inc External preparation for skin, for improving skin barrier function and its production method
JP2008007412A (en) * 2006-06-27 2008-01-17 Maruzen Pharmaceut Co Ltd Involucrin production promoter and epidermal keratinization-normalizing agent

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58113118A (en) * 1981-12-26 1983-07-05 Nonogawa Shoji:Kk Cosmetic
JPS6253911A (en) * 1985-09-02 1987-03-09 Shiseido Co Ltd Cosmetic
JPS6483013A (en) * 1987-09-24 1989-03-28 Narisu Cosmetic Co Ltd Dermal drug for external use
JPH02184613A (en) * 1989-01-09 1990-07-19 Nonogawa Shoji:Kk Skin cosmetic
JPH04305512A (en) * 1991-03-29 1992-10-28 Shiseido Co Ltd External preparation for skin
JPH0820522A (en) * 1994-07-07 1996-01-23 Pola Chem Ind Inc Keratinizing anzyme activity promoter and cosmetic containing the same
JPH1129460A (en) * 1997-07-04 1999-02-02 Pola Chem Ind Inc Cosmetic for sensitive skin
JPH1160496A (en) * 1997-08-13 1999-03-02 Advanced Sukin Res Kenkyusho:Kk Hyaluronic acid production enhancer
JP2000169383A (en) * 1998-12-07 2000-06-20 Ichimaru Pharcos Co Ltd Antiallergic agent
JP2003292432A (en) * 2002-04-04 2003-10-15 Noevir Co Ltd Skin care preparation
JP2003171310A (en) * 2002-05-02 2003-06-20 Noevir Co Ltd Skin barrier function-reinforcing agent
JP2004091376A (en) * 2002-08-30 2004-03-25 Naris Cosmetics Co Ltd Epidermis keratinization normalizing agent and skin care preparation for external use for skin containing the same
JP2005213178A (en) * 2004-01-29 2005-08-11 Maruzen Pharmaceut Co Ltd TNF-alpha PRODUCTION INHIBITOR, ESTROGENIC AGENT AND EXTERNAL PREPARATION FOR SKIN
JP2006056902A (en) * 2005-10-24 2006-03-02 Shiseido Co Ltd Medicament for pruritus, chapped skin, sensitive skin and whitening by suppressing production/release of stem cell factor
JP2007174931A (en) * 2005-12-27 2007-07-12 Pola Chem Ind Inc Epidermal keratinocyte layer membrane and utilization of the epidermal keratinocyte layer membrane
JP2007176835A (en) * 2005-12-27 2007-07-12 Pola Chem Ind Inc External preparation for skin, for improving skin barrier function and its production method
JP2008007412A (en) * 2006-06-27 2008-01-17 Maruzen Pharmaceut Co Ltd Involucrin production promoter and epidermal keratinization-normalizing agent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CSNC200801365022; Fragr. J. Vol.31 No.2, pp.84-93, ▲C▼フレグランス ジャーナル社 *
JPN6012013201; Fragr. J. Vol.31 No.2, pp.84-93, ▲C▼フレグランス ジャーナル社 *
JPN6012039743; Ear Res. Jpn. Vol.18, 1987, pp.314-317 *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009242310A (en) * 2008-03-31 2009-10-22 Kose Corp Involucrin production promoter, transglutaminase-1 production promoter, e-cadherin production promoter and skin care preparation for external use for making skin pore inconspicuous
JP2010105925A (en) * 2008-10-28 2010-05-13 Juntendo Skin keratinization-promoting agent
JP2011088845A (en) * 2009-10-21 2011-05-06 Kao Corp Involucrin expression inhibitor
JP2011088854A (en) * 2009-10-22 2011-05-06 Kao Corp Involucrin expression inhibitor
JP2012171949A (en) * 2011-02-24 2012-09-10 Nagase & Co Ltd Expression enhancer of melatonin receptor and method for producing the same
US20140010901A1 (en) * 2011-03-15 2014-01-09 Shiseido Company, Ltd. Bleomycin hydrolase production promotor
CN102716393A (en) * 2012-06-13 2012-10-10 陈和平 Externally applied traditional Chinese medicine for treating dermatomycosis and bromhidrosis and preparation method of traditional Chinese medicine
JP2014091729A (en) * 2012-11-06 2014-05-19 Fancl Corp Mif secretion inhibitor
JP2014091727A (en) * 2012-11-06 2014-05-19 Fancl Corp Mif secretion inhibitor
US10071042B2 (en) 2014-04-14 2018-09-11 Hayashibara Co., Ltd. External dermatological agent for anti-ageing
KR101872919B1 (en) * 2015-08-28 2018-06-29 주식회사 엘지생활건강 Composition for improving skin
KR20170025361A (en) * 2015-08-28 2017-03-08 주식회사 엘지생활건강 Composition for improving skin
WO2017057420A1 (en) * 2015-09-30 2017-04-06 小林製薬株式会社 Sebum secretion promoter and utilization thereof
JP2017066106A (en) * 2015-09-30 2017-04-06 小林製薬株式会社 Sebum secretion promoter and use thereof
JP2017075117A (en) * 2015-10-14 2017-04-20 丸善製薬株式会社 Barrier function improver
JP2018127407A (en) * 2017-02-07 2018-08-16 日華化学株式会社 Epidermis normalizing agent and external preparation and cosmetic containing the same
JP2019081712A (en) * 2017-10-27 2019-05-30 丸善製薬株式会社 Nerve growth factor expression inhibitor and semaphorin 3A expression promoter
CN107982101A (en) * 2017-11-09 2018-05-04 恩馨(北京)生物科技有限公司 A kind of natural reparative factor, the preparation method and use of effectively reparative regeneration
CN107982101B (en) * 2017-11-09 2020-10-09 恩馨(北京)生物科技有限公司 Natural repair factor capable of effectively repairing and regenerating, preparation method and application thereof
KR20180041107A (en) * 2018-04-16 2018-04-23 주식회사 엘지생활건강 Composition for improving skin
KR102013164B1 (en) * 2018-04-16 2019-08-22 주식회사 엘지생활건강 Composition for improving skin
JP2022161273A (en) * 2021-04-08 2022-10-21 丸善製薬株式会社 Epidermal keratinocyte growth stimulator and transglutaminase-1 mrna expression promoter
JP2023075558A (en) * 2021-11-19 2023-05-31 日本メナード化粧品株式会社 Transglutaminase I production promoter and involucrin production promoter

Similar Documents

Publication Publication Date Title
JP2008007411A (en) Transglutaminase production promoter and epidermal keratinization-normalizing agent
JP2008007412A (en) Involucrin production promoter and epidermal keratinization-normalizing agent
JP2009084216A (en) Atp production promoter and epidermal cell activator
JP4768238B2 (en) Profilagrin mRNA expression promoter
CN102458355A (en) Extracts of whole seeds of Moringa species and their use in cosmetic and/or dermatological compositions
JP5860579B2 (en) Filaggrin production promoter, involucrin production promoter, and transglutaminase-1 production promoter
KR20160125784A (en) Shiunko fermented oil and producing method thereof
JP2009040757A (en) Agent promoting laminin 5 production, agent normalizing dermal basement membrane, and agent promoting recovery of skin lesion
JP2009256271A (en) AQUAPORIN 3 mRNA EXPRESSION PROMOTOR AND SKIN MOISTURE RETENTION FUNCTION-IMPROVING AGENT
JP2008184440A (en) Skin external preparation for improving UV cell damage
JP2009191039A (en) EXPRESSION PROMOTOR FOR HYALURONIC ACID SYNTHETASE 3mRNA, EXPRESSION PROMOTOR FOR AQUAPORIN 3mRNA, EXPRESSION PROMOTOR FOR SERINE PALMITOYLTRANSFERASE mRNA, AND PRODUCTION PROMOTOR FOR LAMININ 5
KR102866606B1 (en) Method of Producing Plant Extracts with Enhanced Physiological Activities, and Cosmetic Composition Containing Plant Extracts with Enhanced Physiological Activities
KR20090070455A (en) Cosmetic composition for preventing skin aging and improving skin wrinkles containing the extract of Licorice as an active ingredient using supercritical extraction
JP2000119125A (en) Skin aging prevention / improvement agent
CN104523479A (en) Application of prinsepiautilis Royle tender bud extractive to whitening product and whitening product
FR2928549A1 (en) USE OF AN EXTRACT OF BRASSOCATTLEYA MARCELLA KOSS ORCHIDEE AS AN AGENT TO PREVENT OR DELAY THE APPEARANCE OF SIGNS OF SKIN AGING
JP2010065007A (en) Claudin-1 production promoter and skin barrier function improving agent
KR101974502B1 (en) Cosmetic composition for anti-allergy and for improving atopic dermatitis comprising extract of anemone reflexa stephan as active ingredient
JP7456720B2 (en) Ceramide production promoter
JP5164198B2 (en) Profilaggrin production promoter, filaggrin production promoter and pore conspicuousness inhibitor
JP2011068570A (en) Laminin-5 production promoter, dermal basement membrane normalizing agent and skin damage recovery promoter
JP2009114146A (en) Transglutaminase-1 production promoter and involucrin production promoter
KR102610940B1 (en) Preparing method of cosmetic composition using skin cosmetic solution
JP2009143833A (en) Extract of crude drug and skin external preparation having the same as active ingredient
KR101730166B1 (en) Use in the cosmetics field of an extract of an exsudate of the plant Daniellia oliveri, in particular as an antiwrinkle agent

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090519

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20090519

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120314

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120514

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120801

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121001

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130306